Merck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning